$10.54 -0.05 (-0.47%)
11/27/2009 12:38 PM

Vanda Pharmaceuticals, Inc. (VNDA)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Featured Broker Partners